APA

Khelif Y., Toutain J., Quittet M., Chantepie S., Laffray X., Valable S., Divoux D., Sineriz F., Pascolo-Rebouillat E., Papy-Garcia D., Barritault D., Touzani O. & Bernaudin M. (20190905). A heparan sulfate-based matrix therapy reduces brain damage and enhances functional recovery following stroke. : Theranostics.

Chicago

Khelif Yacine, Toutain Jérôme, Quittet Marie-Sophie, Chantepie Sandrine, Laffray Xavier, Valable Samuel, Divoux Didier, Sineriz Fernando, Pascolo-Rebouillat Emanuelle, Papy-Garcia Dulce, Barritault Denis, Touzani Omar and Bernaudin Myriam. 20190905. A heparan sulfate-based matrix therapy reduces brain damage and enhances functional recovery following stroke. : Theranostics.

Harvard

Khelif Y., Toutain J., Quittet M., Chantepie S., Laffray X., Valable S., Divoux D., Sineriz F., Pascolo-Rebouillat E., Papy-Garcia D., Barritault D., Touzani O. and Bernaudin M. (20190905). A heparan sulfate-based matrix therapy reduces brain damage and enhances functional recovery following stroke. : Theranostics.

MLA

Khelif Yacine, Toutain Jérôme, Quittet Marie-Sophie, Chantepie Sandrine, Laffray Xavier, Valable Samuel, Divoux Didier, Sineriz Fernando, Pascolo-Rebouillat Emanuelle, Papy-Garcia Dulce, Barritault Denis, Touzani Omar and Bernaudin Myriam. A heparan sulfate-based matrix therapy reduces brain damage and enhances functional recovery following stroke. : Theranostics. 20190905.